Nick Verhaeghe
Overview
Explore the profile of Nick Verhaeghe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
329
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vander Zwalmen Y, Demeester D, Hoorelbeke K, Verhaeghe N, Baeken C, Koster E
J Consult Clin Psychol
. 2025 Feb;
93(3):161-175.
PMID: 40014506
Cognitive control impairments are frequently observed after remission from depression. There is evidence to show that cognitive control training (CCT) can reduce such impairments and related risk for recurrent episodes....
2.
Allemeersch F, Van Lierde K, Verhaeghe N, Bettens K, Mouton T, Hens G, et al.
Int J Lang Commun Disord
. 2025 Feb;
60(2):e70019.
PMID: 40009586
Background: In children with a cleft palate with or without a cleft lip (CP±L), some evidence exists for superior results of high-intensity speech intervention (HISI) compared with low-intensity speech intervention...
3.
Vynckier P, Schmidt M, Nayani S, Guariguata L, Devleesschauwer B, Verhaeghe N
Eur J Public Health
. 2025 Jan;
35(1):108-113.
PMID: 39844617
Tobacco use is among the leading behavioural risk factors for morbidity and mortality. These high rates result in a high cost to society. Therefore, the aim of the current study...
4.
Khan Y, Van den Borre L, De Smedt D, Verhaeghe N, Devleesschauwer B, Deboosere P, et al.
Cancer Med
. 2025 Jan;
14(1):e70487.
PMID: 39778068
Background: The COVID-19 pandemic disrupted global health systems, impacting cancer care and potentially increasing cancer mortality, especially among socioeconomically disadvantaged individuals. We aimed to assess changes in cancer mortality from...
5.
Khan Y, Verhaeghe N, De Pauw R, Devleesschauwer B, Gadeyne S, Gorasso V, et al.
PLoS One
. 2024 Jun;
19(6):e0306495.
PMID: 38935602
[This corrects the article DOI: 10.1371/journal.pone.0288777.].
6.
Meertens A, Van Coile L, Van Iseghem T, Brochez L, Verhaeghe N, Hoorens I
Pharmacoeconomics
. 2024 May;
42(7):751-765.
PMID: 38755518
Background: Skin cancer's rising incidence demands understanding of its economic impact. The current understanding is fragmented because of the various methodological approaches applied in skin cancer cost-of-illness studies. Objective: This...
7.
Visser M, Van Muylder A, Charleer S, Isitt J, Roze S, De Block C, et al.
Diabetologia
. 2024 Jan;
67(4):650-662.
PMID: 38236409
Aims/hypothesis: The aim of this study was to assess the long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring (rtCGM) with alert functionality compared with FreeStyle Libre 1 intermittently scanned...
8.
Khan Y, Verhaeghe N, De Pauw R, Devleesschauwer B, Gadeyne S, Gorasso V, et al.
PLoS One
. 2023 Dec;
18(12):e0295992.
PMID: 38085731
[This corrects the article DOI: 10.1371/journal.pone.0288777.].
9.
Khan Y, Verhaeghe N, Devleesschauwer B, Cavillot L, Gadeyne S, Pauwels N, et al.
Lancet
. 2023 Nov;
402 Suppl 1:S61.
PMID: 37997105
Background: Cardiovascular diseases remain the foremost global cause of death. The COVID-19 pandemic has strained health-care systems, leading to delays in essential medical services, including treatment for cardiovascular diseases. We...
10.
Khan Y, Verhaeghe N, De Pauw R, Devleesschauwer B, Gadeyne S, Gorasso V, et al.
PLoS One
. 2023 Oct;
18(10):e0288777.
PMID: 37903130
Introduction: Cancer causes a substantial burden to our society, both from a health and an economic perspective. To improve cancer patient outcomes and lower society expenses, early diagnosis and timely...